CClinicalTrials.gg
CompletedNCT06487676Updated Jul 5, 2024

Long Term Follow up of Toe-to-hand Transfers

An observational study in Toe Transfer, Free Tissue Flap and Patient Reported Outcome Measures, sponsored by Chang Gung Memorial Hospital. Completed. Per ClinicalTrials.gov, last updated 2024-07-05.

Sponsored by Chang Gung Memorial Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
75
Sex
All
01

Study summary

Toe transfers are perceived to have changed the landscape of the injured hand over the last half century, yet there are limited validated data that unequivocally support the functional role of toe transfers after traumatic digital amputation. There also remain unanswered questions about what factors critically influence functional outcomes, be it sensory recovery, grip strength or other modality. Furthermore, the use of validated patient reported outcome measures (PROMs) in large series of toe transfers with long term follow up, is lacking.

Read the detailed description

Finger amputations are associated with profound impacts on physical, socio-economic, vocational and mental well-being. Thumb amputations account for the greatest burden of disability globally amongst hand trauma.

The multi-centre FRANCHISE study and a recent large prospective multi-centre study have demonstrated that finger replantation outperforms equivalent amputations in nearly all digits at all levels, except for the little finger. However, one crucial question in hand surgery is whether toe transfers can provide a similar functional benefit to replantation.

Finger amputations are frequently not replantable even with timely access to specialized reconstructive care. A review of replantation in the USA found that of 3,417 digital amputations, only 631 replantations were attempted (18%), and of these 30% failed. Therefore nearly 90% of patients with finger amputations will ultimately live without the amputated digit.

Microvascular toe-to-hand transfer, first described in the 1960s, has a success rate close to 100% in high volume centres. There are few validated data that support the functional benefits of toe transfer, with the majority of outcome studies focusing on operative survival rates, physical measurements such as grip strength, or employ unvalidated scales and self-created questionnaires. More data, in larger more representative populations, using validated PROMs, is required.

Here, we aim to demonstrate using PROMS that the role of toe transfers has equivalent or improved functional benefits, with comparison to finger replantation. Additionally, this study aims to identify physical factors that have the greatest influence on patient reported outcomes. This may answer fundamental questions regarding optimum strategies for the design of toe transfers.

02

Conditions studied

  • Toe Transfer
  • Free Tissue Flap
  • Patient Reported Outcome Measures
03

In context

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients operated on by single surgeon (FCW) at Chang Gung Memorial Hospital from 1983 to 2015, with at least 5 years follow up at time of inclusion to study

Inclusion criteria

  • Toe transfers
  • minimum 5 year follow up

Exclusion criteria

Exclusion Criteria:

  • partial toe transfers including toenail, toe pulp or vascularised joint
  • under 5 year follow up
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
75 participants (actual)
Patient registry
No

Groups and cohorts

  • Toe transfer

    Patients who have undergone toe to hand transfer

    Procedure: Toe transfer

  • Replantation

    Patients who have undergone finger replantation

    Procedure: Replantation

Interventions

  • ProcedureToe transfer

    Toe-to-hand transfer

  • ProcedureReplantation

    Finger or thumb replantation after amputation

    Also known as: Finger or thumb replantation

06

What researchers measure

Primary outcomes

  1. Michigan Hand Questionnaire

    Validated Hand function patient reported outcome measured. 0-100. Higher is better

    Time frame: Single time-point, on average 22 years after surgery

Secondary outcomes

  1. Short Form 36

    Short Form 36 Quality of Life. 0-100. Higher is better

    Time frame: Single time-point, on average 22 years after surgery

  2. Foot Function Index

    Validated foot function Patient reported outcome measure. 0-100. Lower is better

    Time frame: Single time-point, on average 22 years after surgery

  3. Aesthetic evaluation

    Subjective evaluation of toe transfer appearance using a Visual Analogue Scale, not validated

    Time frame: Longitudinal. 3 timepoints: 1 day before surgery, 1 day after surgery, and on average 22 years after surgery

Other outcomes

  1. Range of motion

    Total active range of motion of digit. Measured in degrees per digit

    Time frame: Single time-point, on average 22 years after surgery

  2. Grip strength

    Measured with hand dynamometer. Measured in kilograms.

    Time frame: Single time-point, on average 22 years after surgery

  3. Sensation

    Measured with discriminator device. Two point discrimination measured in millimetres

    Time frame: Single time-point, on average 22 years after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — Data subject to privacy and legal restrictions - not yet decided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06487676
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Sponsor
First posted
Jul 5, 2024
Start date
Jul 31, 2015
Primary completion
Oct 27, 2023
Completion
Oct 27, 2023
Last update
Jul 5, 2024

Study contacts

Fu Chan Wei, FACS
principal investigator · Chang Gung Memorial Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion